A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients
University of Chicago
University of Chicago
Jonsson Comprehensive Cancer Center
University of California, San Francisco
Johns Hopkins University
Stanford University
Johns Hopkins University
Fred Hutchinson Cancer Center
Samsung Medical Center